Arvinas

Stories

FDA approves first protein-destroying PROTAC drug for advanced breast cancer

Receives $50M milestone; co-developer of first approved PROTAC

For 25 years, drug companies have tried to design medicines that destroy harmful proteins outright rather than blocking them. On May 1, the U.S. Food and Drug Administration (FDA) approved the first one.

Updated May 31